STOCK TITAN
  1. Home
  2. Sec-filings
  3. BW
  4. [Form 4] Babcock & Wilcox Enterprises, Inc. Insider Trading Activity

Babcock & Wilcox (NYSE: BW) director adds shares via RSU exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Babcock & Wilcox Enterprises director Dr. Homaira Akbari reported equity-based compensation activity. On May 15, 2026, she exercised 3,021 shares of common stock at $21.22 per share from restricted stock units and held 53,021 common shares afterward.

She also received 8,725 new restricted stock units tied to common stock, which vest on May 15, 2027 or the next annual meeting, and previously received 3,021 restricted stock units that vest on May 15, 2026. After these grants, she directly holds both common shares and unvested restricted stock units.

Positive

  • None.

Negative

  • None.
Insider Akbari Dr. Homaira
Role null
Type Security Shares Price Value
Exercise Restricted Stock Units 3,021 $0.00 --
Grant/Award Restricted Stock Units 8,725 $0.00 --
Exercise Common Stock 3,021 $21.22 $64K
Grant/Award Restricted Stock Units 3,021 $0.00 --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 53,021 shares (Direct, null)
Footnotes (1)
  1. Vests May 15, 2026 or date of next Annual Meeting, whichever is earlier. Pursuant to Babcock & Wilcox Enterprises, Inc. Amended and Restated 2021 Long-Term Incentive Plan and represents a contingent right to receive one share of common stock. Vests May 15, 2027 or date of next Annual Meeting, whichever is earlier.
RSUs exercised into common 3,021 shares at $21.22 Exercise of derivative security on May 15, 2026
Common shares held after exercise 53,021 shares Direct ownership following May 15, 2026 transaction
New RSU grant (2026) 8,725 restricted stock units Grant on May 15, 2026 under long-term incentive plan
Prior RSU grant (2026 vesting) 3,021 restricted stock units Grant dated January 29, 2026
Underlying common for new RSUs 8,725 shares Each RSU represents one BW common share
Restricted Stock Units financial
"security_title: Restricted Stock Units; represents a contingent right to receive common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Amended and Restated 2021 Long-Term Incentive Plan financial
"Pursuant to Babcock & Wilcox Enterprises, Inc. Amended and Restated 2021 Long-Term Incentive Plan"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Akbari Dr. Homaira
(Last)(First)(Middle)
1200 E. MARKET STREET, SUITE 650
(Street)
AKRON OHIO 44305
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Babcock & Wilcox Enterprises, Inc. [ BW ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
01/29/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/15/2026M3,021A$21.2253,021D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)05/15/2026M3,021 (1) (1)Common Stock3,021$00D
Restricted Stock Units(1)01/29/2026A3,021 (1) (1)Common Stock3,021$03,021D
Restricted Stock Units(2)05/15/2026A8,725 (3) (3)Common Stock8,725$08,725D
Explanation of Responses:
1. Vests May 15, 2026 or date of next Annual Meeting, whichever is earlier.
2. Pursuant to Babcock & Wilcox Enterprises, Inc. Amended and Restated 2021 Long-Term Incentive Plan and represents a contingent right to receive one share of common stock.
3. Vests May 15, 2027 or date of next Annual Meeting, whichever is earlier.
/s/ John J. Dziewisz, attorney-in-fact for Homaira Akbari05/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did BW director Dr. Homaira Akbari report?

Dr. Homaira Akbari reported equity awards and an option-style exercise. She exercised 3,021 restricted stock units into common stock at $21.22 per share and received additional restricted stock units as compensation, reflecting routine long-term incentive activity rather than open-market buying or selling.

How many Babcock & Wilcox (BW) shares does Dr. Akbari hold after the filing?

After the reported transactions, Dr. Akbari holds 53,021 common shares directly. This figure reflects her position following the May 15, 2026 exercise of 3,021 restricted stock units into common stock, as disclosed in the Form 4 data provided.

What new restricted stock units did Dr. Akbari receive from BW?

Dr. Akbari received 8,725 new restricted stock units on May 15, 2026. These units represent a contingent right to receive an equal number of BW common shares and were granted under the company’s Amended and Restated 2021 Long-Term Incentive Plan.

When do Dr. Akbari’s BW restricted stock units vest?

The filing discloses two vesting schedules for her restricted stock units. One grant vests on May 15, 2026, or the next annual meeting, whichever is earlier, and another vests on May 15, 2027, or the date of the next annual meeting, whichever occurs first.

Were Dr. Akbari’s BW transactions open-market purchases or sales?

The reported BW transactions are not open-market trades. They consist of grants of restricted stock units and the exercise or conversion of previously awarded units, all recorded as acquisitions, rather than discretionary buying or selling of shares in the open market.